MedTrace Logo

Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.

NCT02981225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2018-07-17

No results posted yet for this study

Summary

The purpose of the study is to describe, over 6 weeks, the evolution of depressive symptoms in patients with mild to moderate major depression in a strategy with Phytostandard® Rhodiola-Saffron supplementation

Conditions

  • Mild to Moderate Depression

Interventions

DIETARY_SUPPLEMENT

Phytostandard® Rhodiola-Saffron

Sponsors & Collaborators

  • PiLeJe

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-08
Primary Completion
2017-05-30
Completion
2017-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02981225 on ClinicalTrials.gov